Crossref


2. The role of the gut microbiota in NAFLD

- Christopher Leung

- Leni Rivera

- John B. Furness

- Peter W. Angus

3. Non-pharmacological management options for MAFLD: a practical guide

- José Tadeu Stefano

- Sebastião Mauro Bezerra Duarte

- Renato Gama Ribeiro Leite Altikes

- Claudia P. Oliveira

4. International diet quality index and revised diet quality index relationship with non-alcoholic fatty liver disease: a case-control study

- Narjes Najibi

- Mitra Kazemi Jahromi

- Farshad Teymoori

- Hossein Farhadnejad

- Ammar Salehi-Sahlabadi

- Parvin Mirmiran

8. Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction

- Farnaz Keyhani-Nejad

- Renate Luisa Barbosa Yanez

- Margrit Kemper

- Rita Schueler

- Olga Pivovarova-Ramich

- Natalia Rudovich

- Andreas F.H. Pfeiffer

9. Comment to: “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”

- Jorge Fonseca

- Gonçalo Nunes

- Cristina Fonseca

- Manuela Canhoto

- Ana Teresa Barata

- Carla Adriana Santos

11. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease

- Rodrigo Valenzuela

- Macarena Ortiz

- María Catalina Hernández-Rodas

- Francisca Echeverría

- Luis Alberto Videla

12. Improving the economics of NASH/NAFLD treatment through the use of systems biology

- Jim Bosley

- Christofer Boren

- Sunjae Lee

- Morten Grøtli

- Jens Nielsen

- Mathias Uhlen

- Jan Boren

- Adil Mardinoglu